EP1467782B1 - Pompe a perfusion implantable - Google Patents

Pompe a perfusion implantable Download PDF

Info

Publication number
EP1467782B1
EP1467782B1 EP02769837A EP02769837A EP1467782B1 EP 1467782 B1 EP1467782 B1 EP 1467782B1 EP 02769837 A EP02769837 A EP 02769837A EP 02769837 A EP02769837 A EP 02769837A EP 1467782 B1 EP1467782 B1 EP 1467782B1
Authority
EP
European Patent Office
Prior art keywords
infusion pump
pump according
pump
catheter
pumps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP02769837A
Other languages
German (de)
English (en)
Other versions
EP1467782A1 (fr
Inventor
Hermann L. Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1467782A1 publication Critical patent/EP1467782A1/fr
Application granted granted Critical
Publication of EP1467782B1 publication Critical patent/EP1467782B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00—Machines, pumps, or pumping installations having flexible working members
    • F04B43/08—Machines, pumps, or pumping installations having flexible working members having tubular flexible members
    • F04B43/09—Pumps having electric drive
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00—Machines, pumps, or pumping installations having flexible working members
    • F04B43/08—Machines, pumps, or pumping installations having flexible working members having tubular flexible members
    • F04B43/09—Pumps having electric drive
    • F04B43/095—Piezoelectric drive

Definitions

  • the invention relates to an infusion pump according to the preamble of claim 1.
  • infusion - by infusion means the introduction of liquids, for example in a human or animal body - are known various methods and devices.
  • One known method is the gravitational intravenous injection of a liquid from a container which releases certain quantities of liquid per unit of time, which are supplied via a delivery line, usually a tube, to a vein.
  • a delivery line usually a tube
  • This method and its specific implementation for the device are known under the short name "drip", it is technically modest, reliable, but is only suitable for use in patients whose freedom of movement is subject to restrictions.
  • Pumps essentially comprise a housing in which a refillable media, ie liquid or medicament container and a means for conveying the medium for connection of a delivery line are received starting from said device.
  • the delivery line - also called catheter - can, for example, in the spinal room or in the Bloodstream depending on the medical indication of the recipient.
  • VF pumps are pumps whose flow rate can be set per unit of time, while the flow rate per unit time is unchangeable, ie constant, for CF pumps.
  • the VF pump has to promote the medium from the reservoir for connecting a catheter as a mechanical device to a battery-driven roller pump whose operating parameters such as speed, flow, etc. are electronically adjustable via a chip. In this case, the change in the operating parameters by transferring data from a data processing device, such as a computer via line and read head to the chip.
  • the filling level of the storage tank and thus the consumption over a certain period of time is not measured but calculated with VF pumps. This means that the level does not indicate a refill, but after a predetermined period of time entered on the chip and independent of the remaining stock of media in the storage container is to be refilled.
  • VF pumps ie flow rate deviations from a set flow rate of plus / minus 10% to 15%
  • Residuals are to be withdrawn from the storage container before refilling and can not be used further. With expensive medicines this circumstance makes the operation of a pump more expensive.
  • the adjustable VF pump can take advantage of it take advantage of being able to be programmed at any time according to need, this advantage is offset by the fact that the need-based programming can only be made by specially trained medical professionals, a patient must go to the data processing system due to the transfer by means of a line between the computer and the reading head or vice versa and that relatively large amounts of medication remain to be accepted as a result of inaccuracies
  • a CF pump is simpler in contrast to the VF pump.
  • the medium is conveyed from the reservoir to the catheter connection by means of a pressurized gas cushion, wherein a reducing device is provided between the reservoir and the catheter connection, which determines a flow rate per unit time unvariable.
  • CF pumps are made according to the patient-specific recipe; only the composition of the pumped fluid can be varied, but not the delivery rate and composition as with the VF pump.
  • the time of refilling is determined on the occasion of a previous filling due to the known flow rates.
  • the conveying accuracy i. the accuracy of a flow rate per unit of time is higher than with VF pumps, so that residual quantity measurements do not pose the same problems as with VF pumps.
  • the advantages of the simple structure and a higher delivery accuracy compared to VF pumps and the possibility of refilling by non-specialized medical personnel is therefore faced with the disadvantage of limited adjustment options.
  • Most pumps of the type described are carriers, ie patients, implanted.
  • the implantation takes place in the abdominal area between muscles and skin, ie in the subcutaneous fatty tissue.
  • the housings of the pumps are designed as cans, usually these have a diameter of about 8 cm and a height of about 2 cm to 2.5 cm, the weight of the pump is on the order of about 200 gr. Design and weight
  • the pumps lead after implantation to a cosmetic problem for the patient, as a result of the can shape and the weight of the implantation area undergoes a significant deformation.
  • the pump 10 comprises a housing 11 in which the components of the pump 10 are accommodated.
  • the housing 11 is formed of two equal half-shells, an upper shell 12 and a lower shell 13, which are about their free peripheral edges (edge of the upper shell 14, edge of the lower shell 15) engaged with each other, that is connected.
  • the compound is liquid-tight, so that the components of the pump 10 are sealed sealed against ingress of liquid.
  • the edges 14, 15 of the upper shell 12 and lower shell 13 circumscribe an ellipse, while the outer surfaces 16, 17 of the shells 12, 13 from their midpoints in the longitudinal and transverse directions of the shells 12, 13 radius-shaped to the edges 14, 15th run.
  • the housing 11 of the pump 10 is arcuately deformed, wherein the deformation during implantation is made according to the shape or contour of the implantation site.
  • Pumps are implanted in people in the abdominal region, between the muscle and the skin, ie in the subcutaneous fatty tissue, which absorbs the housing according to the invention without protrusions, ie, away from the implantation site.
  • the upper shell 12 has expansion joints 18, which favor the arcuate deformation, ie the adaptation of the housing 11 to the shape of an implantation site.
  • the upper shell 12 undergoes an expansion, while the lower shell 13 is compressed.
  • the compression can be done without compensation means, but should it be necessary or expedient to compensate or facilitate compression, it may also be provided on the lower shell Kompensationsfugen.
  • Joints 18 are preferably transverse to the longitudinal axis, edge to edge of the shells and are sized to stretch or collapse.
  • Housing 11 are preferably made of plastics, preferably UV (ultra-violet light) curing plastics. UV-curing plastics for housing 11 are advantageous because the housing 11 can be easily plasticized before or during the implantation process, adapted to the shape of the implantation site and then UV cured again.
  • the components accommodated in the housing 11 of the pump 10 include a tank 20 with a plunger 19 for filling the tank, a battery 21, an electronic Control 22, a working on the piezzoelectric principle conveyor 23 (following piezoelectric pump 23 called), conveyors, eg hoses, for conveying the liquid tank contents from the tank 20 to the piezoelectric pump 23 and from there to a side port 29 and electrical lines, the battery 21 with connect the controller 22 and the latter with the piezo pump 23.
  • the tank 20 corresponds in its physical configuration to the inner cavity of the housing 11, but is shortened along its longitudinal axis by a longitudinal axis perpendicular to the circumferential edge 26, so that the other pump components find space in the interior of the housing 11.
  • the tank 20, ie its walls are formed from a flexible, ie flexible, acid and alkali-resistant plastic film, which on one hand carries knobs (not shown), called the following bubble wrap. After fabrication of the tank 20, the nubbed surface of the film forms the inner surface of the tank walls. The knobs prevent the inner surfaces of the walls from sticking together when the tank 20 is empty.
  • a pressure body 27 Surrounding the tank 20 of a pressure body 27.
  • the pressure body 27 is formed of a compressible and expanding plastic foam.
  • Its outer shape corresponds to the shape of the cavity of the housing 11, while its inner shape is dimensioned so that the tank 20 is received with abutting upper and lower tank wall recording. If the tank is filled, it expands and the upper and lower tank wall compresses the foam against the inner surface of the housing 11. By this compression, the foam of the pressure body 27 exerts on the tank 20 back pressure, which is associated with emptying of the tank 20th degrades. With the All-round pressure load of the tank 20 is achieved that it is completely emptied and ensures that the pump 10 operates in any position fluid-promoting.
  • the tank 20 is filled via a valve 19 (also called plunge mandrel 19), which, starting from the upper shell 12, opens out the shell 12, the pressure body 27 and a tank wall in the tank 20.
  • the plunger 19 is basically a valve that can be opened for filling in one direction, is kept closed after filling.
  • the tank 20 has an outlet 30, for example, via a delivery line, e.g. a hose is connected to the input side 31 of the piezo pump 23.
  • a delivery line e.g. a hose is connected to the input side 31 of the piezo pump 23.
  • the input side 31 of the piezo pump 23 is constantly offered fluid.
  • the piezopump 23 is a tube made of piezzoelectric crystals of at least two tube sections 23a and 23b, wherein a current or voltage can be individually applied to each tube section 23a, 23b via lines not illustrated in more detail. It is known that piezzoelectric crystals react to an applied voltage or current by changing their grids. For example, if a voltage is applied to the crystal, the grid expands, the crystal is de-energized, the grid contracts. This effect is used by the piezopump 23, in that a current or a voltage can be applied and switched off at each of the pipe sections 23a, 23b.
  • the pipe sections 23a, 23b If a current or voltage is applied to the pipe sections 23a, 23b, they expand including their holes (bore opens), the power or the voltage is turned off, tighten including hole (bore closes). To generate a pumping process, the pipe sections 23a, 23b are electrically connected in opposite directions. If a current is applied to the pipe section 23a, the described expansion takes place, ie the bore of the pipe section 23a is open and can receive a fluid. During the recording no current is applied to the pipe section 23b, the pipe section 23b is closed.
  • tube section 23a When the fluid intake (filling) in tube section 23a is completed, the current applied to tube section 23a is turned off and a current is applied to tube section 23b, tube section 23a closes and tube section 23b opens, the fluid is discharged from the bore of tube section 23a and flows through the bore of the pipe section 23b (discharge).
  • the tube section 23b When the discharge has been completed, the tube section 23b is de-energized and the tube section 23a is energized, whereupon the pumping process repeats, whereby tube section 23b acts as a check valve in the discharge direction of successively arranged sections in the closed state.
  • the invention is not limited to a piezo pump 23 with two pipe sections 23a, 23b. Piezo pumps according to the invention may be formed from more than two pipe sections. This is expedient when higher pressures of the fluid - the pressure increases in the conveying direction with each pipe section - are required. Supervention, that with increasing number of pipe sections larger and more accurate amounts of fluid can be delivered.
  • the piezo pump 23 according to Fig. 7 comprises three pipe sections 24a, 24b, 24c (hereinafter sections 24a, 24b, 24c called), each of which can be activated piezzoelektrisch, for example by applying a current and deactivated. Shown are 6 circuits (circuits 1 to 6). Each section 24a, 24b, 24c is shown as a rectangle, where a rectangle without a drawn diagonal means that the section open, a rectangle with a drawn diagonal indicates that the section is closed. The arrows indicate the flow direction.
  • circuit 1 a current or voltage is applied to the pump 23 and also to none of its sections 24a, 24b or 24c, the pump is thus closed without current, in which all sections are closed.
  • This is a trained according to the invention security feature by preventing the failure of the battery 21, the closed sections, a penetration of body fluid into the tank 20.
  • circuit 2 a current is applied to section 24a which opens section 24a and is filled from tank 20.
  • the sections 24b and 24c are closed.
  • the portion 24a and 24b is energized, the portion 24b opens and forms with the open portion 24a an enlarged filling space, which in addition to the filling amount in section 24a with a amount corresponding to the portion 24b is filled from the tank 20.
  • the fillings in circuits 2 and 3 are predominantly by suction, whereby the suction process is triggered by the opening of the sections 24a, 24b.
  • the piezo pump 23 and tank 20 are secured against pressurized body fluid by the last closed section (24c) in the direction of flow. A build-up of pressure is created by the filling amount of 24a and 24b is pressed against the closed portion 24c during the closing process of 24a (circuit 4) by the section 24c briefly opens late to section 24a.
  • section 24a is closed, sections 24b and 24c are open.
  • the amount of charge originally taken up in section 24a and section 24b changes under higher pressure into the sections 24b and 24c, whereby a first subset of the filling is carried away.
  • circuit 5 the section closes 24 b, the closing process expresses the second subset of the piezo pump 23 from.
  • circuit 6 In circuit 6 section 24c is closed and section 24a is opened again, the pump has returned to the circuit 2, for a next pumping operation, consisting of filling (circuit 2 and 3), pressure build-up (circuit 3, closing 24a and circuit 4, briefly delayed Opening), discharge (circuit 4 and 5), filling (circuit 6, identical circuit 2).
  • the invention deviates from the way of transferring the pumping function to a tube consisting of at least two pipe sections, which can be piezoelectrically activated and deactivated.
  • Pipes of this type are wear-free, can be operated with lower energy consumption than pumps with mechanical conveyors and pumps according to the invention are characterized in that they are much lighter than known pumps. It is particularly advantageous that the accuracy of each other following flow amounts to more than 99%. This high delivery accuracy entails that in the case of administration of drugs per delivery, smaller amounts of higher concentration than with prior art pumps may be administered.
  • a pipe connects the downstream end of the pump 23 to a port 29, called Side Port 29 hereafter.
  • the side port 29 passes through the lower shell 13 and to him the provided outside the housing 11 catheter 25 is connected with its upstream end A, while the downstream end B promotes depending on the indication, for example in the spinal space or the bloodstream of a recipient.
  • the lower shell 13 has on its outer surface 17 a recess of wave-shaped course, in which the catheter 25 is laid.
  • the side port 29 is once as a catheter connection to the lower shell 13 and as in the catheter connection formed promotional valve, which passes through the upper shell 12, in the outside of the pump 23 to the fluid flow additional fluid quantities, eg drug composition by injection (syringe with needle) are zugebbar. With the pump 23 off, the side port 29 can be used to flush the catheter and for leak testing.
  • valves which consist of medically usable titanium with a valve function executive silicone filling.
  • silicone filling is pierced, for example, with a hollow needle, after filling the hollow needle is withdrawn and closes the piercing opening through the silicone filling.
  • Valves of this type are simple structure without moving parts and are characterized by a high reliability.
  • the implantable battery 21 is electrically connected to the piezo pump 23 via an electronic controller 22 (also called control unit or controller 22).
  • the task of the controller is to supply current from the battery 21 of the piezo pump 23 in a pulse shape.
  • the time sequence between the pulses, the switching on and off of the stream (hereinafter called the total pump pulse) and a subsequent pump pulse is determined by a quartz watch, which triggers the pulses in accordance with certain, respectively summed oscillations via the control unit. These numbers of oscillations are retrievable and changeably stored on a data storage device (microchip).
  • the frequency per unit time with which the pump pulses are triggered is called following the tract frequency.
  • each piezopump 23 is individually calibrated during its manufacture, ie measured individually, whereby each piezopump 23 becomes an identifiable, patient-specific unique item with its own technical data.
  • the maximum flow rate as a constant quantity in relation to the clock frequency allows the chip to calculate information on flow rate, residual quantity, etc. 32 denotes a magnetic switch which can only be activated or deactivated by means of a code and in one of the two states releases the access to the chip of the control unit 22 for the purpose of changing data.
  • From the chip of the electronic controller 22 are also after implantation of the pump 10 as information retrievable the drug, the original capacity, the amount of a Einzelab manner (dose) per pump pulse, the clock frequency, the total amount of beauge kitten drug, the remaining amount in the tank 20, the duration the pump 10, the state of the battery, an identification (registration) of the pump 10 and, if programmed by the doctor, the number of boluses (medication portion) which a patient has additionally administered by means of the pump 10 to the portions pumped by the pump 10 according to the program, for example, supplemented by date and time of additional administrations.
  • the above information is partly calculated or documented by the chip. Calculated, for example, the remaining amount in the tank 10, the state of emergency signals for tank refueling and warning of increased fluid consumption, total amount dispensed, etc.
  • the electronic controller 22 of the pump 10 cooperates with a data processing device 33 (hereinafter called data processor 33) which communicates via a free reading head 34 with the electronic controller 22, ie its data-carrying memory or chip.
  • the data processor 33 such as a conventional personal computer, is available to the physician while the patient has the read head 34, which is not implanted.
  • all therapy and pump operation-specific values are determined by means of a program, stored and transmitted via the read head 34 to the chip of the control device. The transfer is accomplished by the patient holding the read head 34 on the implanted pump 10, ie, bringing the chip and read head 34 into communicative engagement with each other.
  • the read head can pick up data from the chip and send it back to the data processor 33 for revision.
  • control device 22 and data processor 33 remain in contact via read head 34, eg the physician can retrieve data from the chip via read head 34, compare it, change it for therapeutic purposes and forward it to the chip again .
  • the data transfer from data processor 33 to read head 34 is made via telephone lines or similar telephone exchanges using the so-called tone dialing method which allocates and transmits data and tones in different pitches. This type of data transmission is possible over long distances, so that the doctor can perform therapeutic measures even with a large distanced separation to the patient.
  • the reading head 34 can be combined with a signal generator 35, which triggers only the bolus delivery.
  • the pump 10 according to the invention is characterized as described by two modes.
  • the first mode (Mode 1) is the delivery of certain amounts within a given clock frequency
  • the second mode (Mode 2) encloses the first, if necessary supplemented by the delivery of additional amounts (bolus).
  • Mode 1 relies on the experience of the physician, who strives to come as close as possible to his therapeutic objective with respect to quantities, frequency of deliveries, composition of medicaments, etc. If insufficiencies, eg the blood sugar content of a diabetic patient, do not fluctuate, then it is sufficient to operate the pump 10 without bolus levies in accordance with the medical prescription (programmed insulin delivery).
  • Mode 2 is preferred since Mode 2 complements or modifies the physician's prescriptions for Mode 1 to eliminate the patient's disorders. If it is assumed that Mode 1 follows medical knowledge and generally accepted rules of experience, ie includes an objectified therapeutic prescription, then Mode 2 adds a subjective sensation element that does not allow any conclusions to be drawn about the magnitude of the fluctuation fluctuations.
  • a surge sensor measuring sensor (not shown) may be provided for bolus delivery which measures and adjusts excursions of set values according to mode 1 If the pump 10 is exceeded or undershot, ie the chip of the control unit 22, issued the order to promote additional quantities / reduced quantities to compensate for the fluctuation fluctuations.
  • sensors may be implanted in the bloodstream in diabetes or, where indicated, worn on the body.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Mechanical Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Claims (12)

  1. Pompe à perfusion comprenant un boîtier implantable, un réservoir contenu dans le boîtier et pouvant être rempli avec un fluide muni d'une pointe d'injection et d'une sortie, d'un cathéter, d'un dispositif de refoulement disposé entre entre le réservoir et le cathéter et alimenté par une batterie, dont le débit est réglable via un contrôleur électronique, le dispositif de refoulement (23) étant configuré pour fonctionner par un principe piézoélectrique, caractérisé en ce que la surface extérieure 16 de la coque supérieure (12) du boîtier (11) comporte des joints de dilatation (18).
  2. Pompe à perfusion selon la revendication 1, caractérisé en ce que le dispositif de refoulement (23) est un tube (pompe piézo 23) réalisé de cristaux piézoélectriques, comprenant au moins deux portions de tube (23a) et (23b), aux portions de tube (23a) et (23b) duquel peut être appliqué un courant ou une tension électrique.
  3. Pompe à perfusion selon la revendication 1 ou 2, caractérisé en ce que la pompe piézo (23) refoule d'un côté d'une ouverture latérale (29) lors de la fermeture d'une des portions de tube (23a) et (23b), et qu'un cathéter (25) peut être connecté de l'autre côté de l'ouverture latérale (29).
  4. Pompe à perfusion selon l'une des revendications 1 à 3, caractérisée en ce que la surface extérieure (17) de la coque inférieure (13) comporte à partir de l'ouverture latérale (29), une extension ondulée dans laquelle se loge le cathéter (25) connecté à l'ouverture latérale (29).
  5. Pompe à perfusion selon l'une des revendications 1 à 4, caractérisée en ce que le réservoir (20) est réalisé à partir d'un film souple et comporte des bossages sur sa surface interne.
  6. Pompe à perfusion selon l'une des revendications 1 à 5, caractérisée en ce que le réservoir (20) est logé dans un corps de pression (27) formé de mousse en matière plastique compressible.
  7. Pompe à perfusion selon l'une des revendications 1 à 6, caractérisée en ce qu'un contrôleur (22) pour l'activation et la désactivation des portions de tube (23a) et (23b) est disposé entre la batterie (21) et la pompe piézo (23).
  8. Pompe à perfusion selon l'une des revendications 1 à 7, caractérisée en ce que l'activation ou la désactivation à lieu par application d'un courant ou d'une tension aux portions de tube (23a) et (23b).
  9. Pompe à perfusion selon l'une des revendications 1 à 8, caractérisée en ce que le contrôleur (22) est programmable au moyen d'un dispositif de traitement de données (33) et d'une tête de lecture (34) communiquant avec le dispositif de traitement de données (33).
  10. Pompe à perfusion selon l'une des revendications 1 à 9, caractérisée en ce que la communication est réalisée par une liaison téléphonique ou un dispositif de transmission téléphonique semblable.
  11. Pompe à perfusion selon l'une des revendications 1 à 10, caractérisée en ce que des données sont codées et transmises selon le mode en fréquence vocale.
  12. Pompe à perfusion selon l'une des revendications 1 à 11, caractérisée en ce que la tête de lecture (34) comporte un émetteur de signal (35) pour la délivrance d'un bolus.
EP02769837A 2001-11-06 2002-11-06 Pompe a perfusion implantable Expired - Lifetime EP1467782B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH203401 2001-11-06
CH02034/01A CH696661A5 (de) 2001-11-06 2001-11-06 Infusionspumpe.
PCT/CH2002/000596 WO2003039631A1 (fr) 2001-11-06 2002-11-06 Pompe a perfusion

Publications (2)

Publication Number Publication Date
EP1467782A1 EP1467782A1 (fr) 2004-10-20
EP1467782B1 true EP1467782B1 (fr) 2010-04-14

Family

ID=4567227

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02769837A Expired - Lifetime EP1467782B1 (fr) 2001-11-06 2002-11-06 Pompe a perfusion implantable

Country Status (15)

Country Link
US (1) US7601148B2 (fr)
EP (1) EP1467782B1 (fr)
JP (1) JP2005507757A (fr)
KR (1) KR20040076858A (fr)
CN (1) CN100467076C (fr)
AT (1) ATE464081T1 (fr)
AU (1) AU2002363359B2 (fr)
CA (1) CA2469217A1 (fr)
CH (1) CH696661A5 (fr)
DE (1) DE50214373D1 (fr)
IL (2) IL161817A0 (fr)
NZ (1) NZ533357A (fr)
RU (1) RU2308978C2 (fr)
WO (1) WO2003039631A1 (fr)
ZA (1) ZA200404055B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8221354B2 (en) 2006-04-27 2012-07-17 Medtronic, Inc. Infusion device with positive pressure elastic bladder reservoir
DE102007047353A1 (de) * 2007-10-02 2009-04-09 B. Braun Melsungen Ag Fördervorrichtung und Verfahren für die Zuführung eines Medikamenten-Lösungsgemisches
US8105269B2 (en) 2008-10-24 2012-01-31 Baxter International Inc. In situ tubing measurements for infusion pumps
US8137083B2 (en) 2009-03-11 2012-03-20 Baxter International Inc. Infusion pump actuators, system and method for controlling medical fluid flowrate
US7806865B1 (en) * 2009-05-20 2010-10-05 Alcon Research, Ltd. Pressurized irrigation squeeze band
US20110152697A1 (en) * 2009-12-18 2011-06-23 K&Y Corporation Circulatory Pressure Monitoring Using Infusion Pump Systems
US8480622B2 (en) * 2009-12-18 2013-07-09 Sims Infusion pump
US20110152829A1 (en) * 2009-12-18 2011-06-23 K&Y Corporation Patient Fluid Management System
US8382447B2 (en) 2009-12-31 2013-02-26 Baxter International, Inc. Shuttle pump with controlled geometry
KR101963799B1 (ko) * 2010-02-17 2019-03-29 플로우 포워드 메디컬, 인크. 정맥의 전체 직경을 증가시키는 방법 및 시스템
JP5549285B2 (ja) 2010-03-09 2014-07-16 株式会社リコー 圧電素子駆動回路
US8567235B2 (en) 2010-06-29 2013-10-29 Baxter International Inc. Tube measurement technique using linear actuator and pressure sensor
KR101127126B1 (ko) * 2011-08-31 2012-03-21 서현배 압전 작동 인퓨전펌프
CN103127584B (zh) * 2013-03-21 2014-08-06 北京伏尔特技术有限公司 流量设定微调装置
WO2016176192A1 (fr) 2015-04-27 2016-11-03 Maguire Shane Cathéter de pompage pour perfusion implantable
CN104971402A (zh) * 2015-06-25 2015-10-14 佛山可为医疗科技有限公司 一种精密药物输注系统
US10634143B2 (en) 2015-12-23 2020-04-28 Emerson Climate Technologies, Inc. Thermal and sound optimized lattice-cored additive manufactured compressor components
US10557464B2 (en) 2015-12-23 2020-02-11 Emerson Climate Technologies, Inc. Lattice-cored additive manufactured compressor components with fluid delivery features
US10982672B2 (en) 2015-12-23 2021-04-20 Emerson Climate Technologies, Inc. High-strength light-weight lattice-cored additive manufactured compressor components
CN206372358U (zh) * 2016-09-13 2017-08-04 吴正才 新型输液仪

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2891700A (en) * 1956-11-19 1959-06-23 Gestetner Ltd Collapsible containers
DE2421433A1 (de) * 1974-05-03 1975-11-13 Braun Melsungen Ag Flachbeutel aus folien von thermoplastischen kunststoffen fuer biologische und therapeutische fluessigkeiten
US3995628A (en) * 1975-04-25 1976-12-07 Travenol Laboratories, Inc. Catheter insertion device
DE2652026C2 (de) * 1976-11-15 1983-01-05 Siemens AG, 1000 Berlin und 8000 München Gerät zur Infusion von Flüssigkeiten
US4519751A (en) * 1982-12-16 1985-05-28 The Abet Group Piezoelectric pump with internal load sensor
FR2548431B1 (fr) 1983-06-30 1985-10-25 Thomson Csf Dispositif a commande electrique de deplacement de fluide
IL69431A (en) * 1983-08-04 1987-12-31 Omikron Scient Ltd Liquid delivery system particularly useful as an implantable micro-pump for delivering insulin or other drugs
CA1295582C (fr) * 1983-10-17 1992-02-11 Debra Cheryl Boone Tube pour contenant comprimable
US4822250A (en) * 1986-03-24 1989-04-18 Hitachi, Ltd. Apparatus for transferring small amount of fluid
GB8701731D0 (en) * 1987-01-27 1987-03-04 Patcentre Benelux Nv Sa Pumps
DE3831809A1 (de) * 1988-09-19 1990-03-22 Funke Hermann Zur mindestens teilweisen implantation im lebenden koerper bestimmtes geraet
JPH02126860A (ja) * 1988-11-08 1990-05-15 Olympus Optical Co Ltd 体内埋込み型マイクロポンプ
CH680009A5 (en) 1989-06-14 1992-05-29 Westonbridge Int Ltd Micro-pump-for injection of medication dose
KR920701670A (ko) 1989-06-14 1992-08-12 원본미기재 개선된 마이크로펌프(micropump).
US5336188A (en) * 1989-06-16 1994-08-09 Science Incorporated Fluid delivery apparatus having a stored energy source
US5354282A (en) * 1990-05-04 1994-10-11 Bierman Steven F Catheter anchoring system
US5176641A (en) * 1991-07-08 1993-01-05 Infusaid, Inc. Implantable drug infusion reservoir having fluid impelling resilient foam member
US5569187A (en) * 1994-08-16 1996-10-29 Texas Instruments Incorporated Method and apparatus for wireless chemical supplying
WO1997027829A1 (fr) * 1996-01-31 1997-08-07 The Trustees Of The University Of Pennsylvania Dispositif d'administration de medicament commande a distance
US6074178A (en) * 1997-04-15 2000-06-13 Face International Corp. Piezoelectrically actuated peristaltic pump
EP1189647B1 (fr) * 1999-04-28 2003-10-22 Sten-Olof Elfver Systeme de distribution de medicament implantable
US6464671B1 (en) 1999-04-28 2002-10-15 Sten-Olof Elver Medical system

Also Published As

Publication number Publication date
US20050063838A1 (en) 2005-03-24
NZ533357A (en) 2006-04-28
JP2005507757A (ja) 2005-03-24
AU2002363359B2 (en) 2006-07-27
ZA200404055B (en) 2004-09-02
CN1612760A (zh) 2005-05-04
RU2308978C2 (ru) 2007-10-27
US7601148B2 (en) 2009-10-13
RU2004117070A (ru) 2005-03-10
ATE464081T1 (de) 2010-04-15
CA2469217A1 (fr) 2003-05-15
DE50214373D1 (de) 2010-05-27
CN100467076C (zh) 2009-03-11
IL161817A (en) 2009-06-15
CH696661A5 (de) 2007-09-14
EP1467782A1 (fr) 2004-10-20
IL161817A0 (en) 2005-11-20
KR20040076858A (ko) 2004-09-03
WO2003039631A1 (fr) 2003-05-15

Similar Documents

Publication Publication Date Title
EP1467782B1 (fr) Pompe a perfusion implantable
DE60132507T2 (de) Gerät zur transkutanen Abgabe von Medikamenten
DE69921809T2 (de) Von Patienten gesteuerte Medikamentenverabreichungsvorrichtungen
EP0242351B1 (fr) Dispositif pour délivrer un médicament liquide à débit constant
US6656159B2 (en) Dispenser for patient infusion device
US4013074A (en) Implantable medication-dispensing device
DE69913111T2 (de) Vorrichtung zur arzneimittelverarbreichung
DE2513467C3 (de) Gerät zur Infusion von Flüssigkeiten in den menschlichen oder tierischen Körper
US4443218A (en) Programmable implantable infusate pump
DE60128826T2 (de) Infusionsvorrichtung und System
US6723072B2 (en) Plunger assembly for patient infusion device
EP1691883B1 (fr) Distributeur pour dispositifs d'infusion pour patient
DE2652026C2 (de) Gerät zur Infusion von Flüssigkeiten
US20060041229A1 (en) Flow restriction system and method for patient infusion device
DE69726600T2 (de) Vorrichtung zur arzneimittelverabreichung
CN205031650U (zh) 低成本流体输送设备
ITRM20010090A1 (it) Dispositivo e metodo per guidare e limitare l'accesso di aghi ipodermici al setto di un dispositivo impiantabile in esseri umani per trattam
EP1531888B2 (fr) Pompe de perfusion pour l'administration dosee d'un liquide medical
EP1576976B1 (fr) Analgésie régulée par le patient pour la perfusion continuée et l'administration additionnelle d'une solution médicamenteuse
USRE35192E (en) Post-surgical anesthesia at a continuous and progressively decreasing administration rate
DE19648326A1 (de) Gerät zum Verabreichen flüssiger Medikamente
DE3639980C1 (en) Device for administration of metered individual doses of a medicament
CN219049817U (zh) 一种镇痛泵
DE60006109T2 (de) Implantierbares medikamentenabgabesystem
DD247151A1 (de) Anordnung zur beseitigung des restinfusats bei dampfdruckgetriebenen infusionspumpen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

17Q First examination report despatched

Effective date: 20090129

RTI1 Title (correction)

Free format text: IMPLANTABLE INFUSION PUMP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REF Corresponds to:

Ref document number: 50214373

Country of ref document: DE

Date of ref document: 20100527

Kind code of ref document: P

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20100414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100725

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100715

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100816

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

26N No opposition filed

Effective date: 20110117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

BERE Be: lapsed

Owner name: KELLER, HERMANN L.

Effective date: 20101130

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20101215

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101130

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 464081

Country of ref document: AT

Kind code of ref document: T

Effective date: 20101106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101106

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 50214373

Country of ref document: DE

Effective date: 20130601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100714

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130601

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20191121

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20191125

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20191126

Year of fee payment: 18

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20201106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201106